2012
Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer
CIBULA, D., R.D. ABU-RUSTUM, Ladislav DUŠEK, M. ZIKÁN, A. ZAAL et. al.Základní údaje
Originální název
Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer
Autoři
CIBULA, D. (203 Česká republika, garant), R.D. ABU-RUSTUM (840 Spojené státy), Ladislav DUŠEK (203 Česká republika, domácí), M. ZIKÁN (203 Česká republika), A. ZAAL (528 Nizozemské království), L. SEVCIK (203 Česká republika), G.G. KENTER (528 Nizozemské království), D. QUERLEU (250 Francie), R. JACH (616 Polsko), A.S. BATS (250 Francie), G. DYDUCH (616 Polsko), P. GRAF (203 Česká republika), J. KLAT (203 Česká republika), J. LACHETA (203 Česká republika), C.J.L.M. MEIJER (528 Nizozemské království), E. MERY (250 Francie), R. VERHEIJEN (528 Nizozemské království) a R.P. ZWEEMER (528 Nizozemské království)
Vydání
Gynecologic Oncology, 2012, 0090-8258
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30214 Obstetrics and gynaecology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 3.929
Kód RIV
RIV/00216224:14110/12:00059783
Organizační jednotka
Lékařská fakulta
UT WoS
000300751900021
Klíčová slova anglicky
Cervical cancer; Sentinel node; Micrometastasis; Isolated tumor cells; Low volume disease
Příznaky
Mezinárodní význam
Změněno: 26. 4. 2012 10:01, Mgr. Michal Petr
Anotace
V originále
Evaluate prognostic significance of low volume disease detected in sentinel nodes (SN) of patients with early stages cervical cancer. Although pathologic ultrastaging of SN allows for identification of low volume disease, including micro-metastasis and isolated tumor cells (ITC), in up to 15% of cases, prognostic significance of these findings is unknown. Methods: A total of 645 records from 8 centers were retrospectively reviewed. Enrolled in our study were patients with early-stage cervical cancer who had undergone surgical treatment including SN biopsy followed by pelvic lymphadenectomy and pathologic ultrastaging of SN. Results: Macrometastasis, micrometastasis, and ITC were detected by SN ultrastaging in 14.7%, 10.1%, and 4.5% patients respectively. False negativity of SN ultrastaging reached 2.8%. The presence of ITC was not associated with significant risk, both for recurrence free survival and overall survival. Overall survival was significantly reduced in patients with macrometastasis and micrometastasis; hazard ratio for overall survival reached 6.85 (95% CI, 2.59–18.05) and 6.86 (95% CI, 2.09–22.61) respectively. Presence of micrometastasis was an independent prognostic factor for overall survival in a multivariable model. Conclusion: Presence of micrometastasis in SN in patients with early stage cervical cancer was associated with significant reduction of overall survival, which was equivalent to patients with macrometastasis. No prognostic significance was found for ITC. These data highlight the importance of SN biopsy and pathologic ultrastaging for the management of cervical cancer.